[CYCC] QoQ Quarter Result on 30-Jun-2016 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
11-Aug-2016
Financial Year
2016
Quarter
30-Jun-2016 [#Q2]
Profit Trend
QoQ- 2.50%
YoY- 11.41%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
Revenue 0 277 205 222 139 424 715 -
PBT -1,861 -3,249 -3,400 -3,591 -3,534 -3,872 -3,187 -30.11%
Tax -306 -409 -454 -626 -493 -498 -478 -25.70%
NP -1,555 -2,839 -2,946 -2,965 -3,041 -3,374 -2,709 -30.90%
Tax Rate - - - - - - - -
Total Cost 1,555 3,116 3,151 3,187 3,180 3,798 3,424 -40.88%
Ratio Analysis
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
NP Margin 0.00 -1,024.91 -1,437.07 -1,335.59 -2,187.77 -795.75 -378.88 -
Per Share
31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 30/09/15 CAGR
EPS -7.28 -13.34 -16.96 -19.77 -20.51 -23.15 -18.75 -46.74%
EPS Diluted -7.28 -13.34 -16.96 -19.77 -20.51 -23.15 -18.75 -46.74%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.